Top

Published in:

Open Access 01-12-2022 | Migraine | Research

Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study

Authors: Holly M. Crowe, Amelia K. Wesselink, Lauren A. Wise, Susan S. Jick, Kenneth J. Rothman, Ellen M. Mikkelsen, Henrik T. Sørensen, Elizabeth E. Hatch

Published in: The Journal of Headache and Pain | Issue 1/2022

Abstract

Background

Migraine is common among females of reproductive age (estimated prevalence:17–24%) and may be associated with reproductive health through underlying central nervous system excitability, autoimmune conditions, and autonomic dysfunction. We evaluated the extent to which pre-pregnancy migraine diagnosis and medication use are associated with risk of spontaneous abortion (SAB).

Methods

We analyzed data from a preconception study of pregnancy planners (2013–2021). Eligible participants self-identified as female, were aged 21–45 years, resided in the USA or Canada, and conceived during follow-up (n = 7890). Participants completed baseline and bimonthly follow-up questionnaires for up to 12 months or until a reported pregnancy, whichever occurred first. Pregnant participants then completed questionnaires during early (~ 8–9 weeks) and late (~ 32 weeks) gestation. We defined migraineurs as participants who reported a migraine diagnosis or use of a medication to treat migraine. Preconception questionnaires elicited migraine medication use during the past 4 weeks, and SAB on follow-up and pregnancy questionnaires. We used Cox regression models with gestational weeks as the time scale to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations among preconception migraine, migraine medication use, and SAB, controlling for potential demographic, medical, and lifestyle confounders.

Results

Nineteen percent of study pregnancies ended in SAB. History of migraine before conception was not appreciably associated with SAB risk (HR = 1.03, 95% CI: 0.91–1.06). Use of any migraine medication was associated with a modest increase in SAB risk overall (HR = 1.14, 95% CI: 0.96–1.36). We observed the greatest increase in risk among those taking migraine medications daily (HR = 1.38, 95% CI: 0.81–2.35) and those taking prescription migraine prophylaxis (HR = 1.43, 95% CI: 0.72–2.84) or combination analgesic and caffeine medications (HR = 1.42, 95% CI: 0.99–2.04).

Conclusions

Migraine medication use patterns suggesting greater underlying migraine severity were associated with increased risk of SAB. This research adds to the limited information available on the reproductive effects of migraine.

Lipton RB, Bigal M E, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine Prevalence, Disease Burden, and the Need for Preventive Therapy.; 2007

Peterlin BL, Katsnelson MJ, Calhoun AH (2009) The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep 13(5):404–412. https://doi.org/10.1007/s11916-009-0066-1CrossRef

Dahlöf, Carl G.H, Soloman GD. The burden of migraine to the individual suffer: a review. Eur J Neurol 1998;5(6):525–533

Tanos V, Raad EA, Berry KE, Toney ZA (2019) Review of migraine incidence and management in obstetrics and gynaecology. Eur J of Obstet and Gynecol and Reprod Biol 240:248–255. https://doi.org/10.1016/j.ejogrb.2019.07.021CrossRef

Steiner TJ, Stovner LJ, Jensen R, Uluduz D, Katsarava Z (2020) Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019. J Headache Pain 21(1). https://doi.org/10.1186/S10194-020-01208-0

Alberman E (1992) Spontaneous abortions: epidemiology. In: Spontaneous Abortion. Springer, London, UK, pp 9–20. https://doi.org/10.1007/978-1-4471-1918-0_2CrossRef

Rossen LM, Ahrens KA, Branum AM (2018) Trends in risk of pregnancy loss among US women, 1990–2011. Paediatr Perinat Epidemiol 32(1):19–29. https://doi.org/10.1111/ppe.12417CrossRef

Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss | Elsevier Enhanced Reader. Accessed January 24, 2022. https://reader.elsevier.com/reader/sd/pii/S0140673621006826?token=BFE7707985B36818143A65FD84F55ECE378F474E9242C8980BE2218598BA6170EB56B5BDE1664B1BAAA45ADC75014ECA&originRegion=us-east-1&originCreation=20220124175338

Thom DH, Nelson LM, Vaughan TL (1992) Spontaneous abortion and subsequent adverse birth outcomes. Am J Obstet Gynecol 166(1):111–116. https://doi.org/10.1016/0002-9378(92)91841-WCrossRef

10.

Ali N, Elbarazi I, Ghazal-Aswad S et al (2020) Impact of recurrent miscarriage on maternal outcomes in subsequent pregnancy: the mutaba’ah study. Int J Women's Health 12:1171–1179. https://doi.org/10.2147/IJWH.S264229CrossRef

11.

Edlow AG, Srinivas SK, Elovitz MA (2007) Second-trimester loss and subsequent pregnancy outcomes: what is the real risk? Am J Obstet Gynecol 197(6):581.e1–581.e6. https://doi.org/10.1016/j.ajog.2007.09.016CrossRef

12.

Skajaa N, Szépligeti SK, Xue F et al (2019) Pregnancy, birth, neonatal, and postnatal neurological outcomes after pregnancy with migraine. Headache: the journal of head and face. Pain. 59(6):869–879. https://doi.org/10.1111/head.13536CrossRef

13.

Allais G, Chiarle G, Sinigaglia S, Mana O, Benedetto C (2019) Migraine during pregnancy and in the puerperium. Published online. https://doi.org/10.1007/s10072-019-03792-9

14.

Sanchez SE, Qiu C, Williams MA, Lam N, Sorensen TK (2008) Headaches and migraines are associated with an increased risk of preeclampsia in Peruvian women. Am J Hypertens 21(3):360–364. https://doi.org/10.1038/ajh.2007.46CrossRef

15.

Germain AM, Romanik MC, Guerra I et al (2007) Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertens 49(1):90–95. https://doi.org/10.1161/01.HYP.0000251522.18094.d4CrossRef

16.

Bánhidy F, Ács N (2007) Pregnancy complications and delivery outcomes in pregnant women with severe migraine. Eur J Obstet Gynecol Reprod Biol 134(2):157–163. https://doi.org/10.1016/j.ejogrb.2006.08.025CrossRef

17.

Strumpf E, Lang A, Austin N et al (2021) Prevalence and clinical, social, and health care predictors of miscarriage. BMC Pregnancy Childbirth 21(1):1–9. https://doi.org/10.1186/S12884-021-03682-Z/TABLES/2CrossRef

18.

Griebel CP, Halvorsen J, Golemon TB, Day AA (2005) Management of Spontaneous Abortion. Am fam physician 72(7):1243–1250

19.

Wilcox AJ, Weinberg CR, O’Connor JF et al (1988) Incidence of early loss of pregnancy. N Engl J Med 319(4):189–194. https://doi.org/10.1056/NEJM198807283190401CrossRef

20.

Alves C, Rapp A. Spontaneous Abortion. StatPearls. Published online July 18, 2022:1–11

21.

Bérard A, Kori S (2012) Dihydroergotamine (DHE) use during gestation and the risk of adverse pregnancy outcomes. Headache. 52(7):1085–1093. https://doi.org/10.1111/j.1526-4610.2012.02172.xCrossRef

22.

Marchenko A, Etwel F, Olutunfese O, Nickel C, Koren G, Nulman I (2015) Pregnancy outcome following prenatal exposure to Triptan medications: a Meta-analysis. Headache: the journal of head and face. Pain. 55(4):490–501. https://doi.org/10.1111/head.12500CrossRef

23.

Kumar S (2011) Occupational, environmental and lifestyle factors associated with spontaneous abortion. Reprod Sci 18(10):915–930. https://doi.org/10.1177/1933719111413298CrossRef

24.

Wise LA, Rothman KJ, Mikkelsen EM et al (2015) Design and conduct of an internet-based preconception cohort study in North America: pregnancy study online. Paediatr Perinat Epidemiol 29(4):360–371. https://doi.org/10.1111/ppe.12201CrossRef

25.

Cohen S, Kamarck T, Mermelstein R (1983) A global measure of perceived stress. J Health Soc Behav 24(4):385–396CrossRef

26.

Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W (2001) The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord 66(2–3):159–164. https://doi.org/10.1016/s0165-0327(00)00309-8CrossRef

27.

Liu Y, De A (2015) Multiple imputation by fully conditional specification for dealing with missing data in a large epidemiologic study. Int J Stat Med Res 4(3):287. https://doi.org/10.6000/1929-6029.2015.04.03.7CrossRef

28.

Cox’s Regression Model for Counting Processes: A Large Sample Study on JSTOR. Accessed August 15, 2022. https://www.jstor.org/stable/2240714

29.

Cox DR. 972] 187 Regression Models and Life-Tables

30.

Be A, Wl H, Mc W et al (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504. https://doi.org/10.1097/00005768-200009001-00009CrossRef

31.

Ainsworth BE, Haskell WL, Herrmann SD et al (2011) Compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc Published online 2011. https://doi.org/10.1249/MSS.0b013e31821ece12

32.

Lassi ZS, Imam AM, Dean SV, Bhutta ZA (2014) Preconception care: caffeine, smoking, alcohol, drugs and other environmental chemical/radiation exposure. Reprod Health 11(3):1–12. https://doi.org/10.1186/1742-4755-11-S3-S6/FIGURES/8CrossRef

33.

Hultzsch S, Paulus W, Padberg S, Fietz AK, Schaefer C, Dathe K (2021) First trimester naproxen exposure and outcome of pregnancy - a German case series. Reprod Toxicol 103:51–57. https://doi.org/10.1016/j.reprotox.2021.05.006CrossRef

34.

Ying XH, Bao DN, Jiang HY, Shi YD (2022) Maternal non-steroidal anti-inflammatory drug exposure during pregnancy and risk of miscarriage: a systematic review and meta-analysis. Eur J Clin Pharmacol 78(2):171–180. https://doi.org/10.1007/s00228-021-03222-wCrossRef

35.

Vatzaki E, Straus S, Dogne JM, Garcia Burgos J, Girard T, Martelletti P (2018) Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European medicines agency and European headache federation. J Headache Pain. 19(1):68. https://doi.org/10.1186/s10194-018-0898-3CrossRef

36.

(2010) American College of Obstetricians and Gynecologists. Moderate Caffeine Consumption During Pregnancy COMMITTEE OPINION 462(116):467–468

37.

(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1–211. https://doi.org/10.1177/0333102417738202

38.

Qiu C, Williams MA, Aurora SK et al (2013) Agreement of self-reported physician diagnosis of migraine with international classification of headache disorders-II migraine diagnostic criteria in a cross-sectional study of pregnant women. BMC Womens Health 13(1):50. https://doi.org/10.1186/1472-6874-13-50CrossRef

39.

Zhang Y, Xu T, Wang Z et al (2021) Differences in topological properties of functional brain networks between menstrually-related and non-menstrual migraine without aura. Brain Imaging Behav 15(3):1450–1459. https://doi.org/10.1007/S11682-020-00344-0CrossRef

40.

Altamura C, Cascio Rizzo A, Maggio P et al (2019) Prevalence and clinical profile of migraine with aura in a cohort of young patients with stroke: a preliminary retrospective analysis. Neurol Sci Published online. https://doi.org/10.1007/s10072-019-03815-5

41.

Grossman TB, Robbins MS, Govindappagari S, Dayal AK (2017) Delivery outcomes of patients with acute migraine in pregnancy: a retrospective study. Headache. 57(4):605–611. https://doi.org/10.1111/head.13023CrossRef

42.

Banerjee P, Ghosh S, Dutta M, et al. Identification of key contributory factors responsible for vascular dysfunction in idiopathic recurrent spontaneous miscarriage. PLoS One 2013;8(11):e80940. doi:https://doi.org/10.1371/JOURNAL.PONE.0080940

43.

Wood ME, Burch RC, Hernandez-Diaz S (2021) Polypharmacy and comorbidities during pregnancy in a cohort of women with migraine. Cephalalgia. 41(3):392–403. https://doi.org/10.1177/0333102420975394CrossRef

44.

Rothman KJ, Poole C (1988) A strengthening programme for weak associations. Int J Epidemiol 17(4):955–959. https://doi.org/10.1093/IJE/17.4.955CrossRef

45.

Hatch EE, Hahn KA, Wise LA et al (2016) Evaluation of selection Bias in an internet-based study of pregnancy planners. Epidemiol 27(1):98–104. https://doi.org/10.1097/EDE.0000000000000400CrossRef

Title: Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study
Authors: Holly M. Crowe
Amelia K. Wesselink
Lauren A. Wise
Susan S. Jick
Kenneth J. Rothman
Ellen M. Mikkelsen
Henrik T. Sørensen
Elizabeth E. Hatch
Publication date: 01-12-2022
Publisher: Springer Milan
Keywords: Migraine
Miscarriage
Triptan Drugs
Published in: The Journal of Headache and Pain / Issue 1/2022
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-022-01533-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study

Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study

Real-World experience of interictal burden and treatment in migraine: a qualitative interview study

Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients

Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)